<i>CYP2C9</i> polymorphism is associated with susceptibility to ischemic stroke in a Chinese population. [PDF]
Zhang J +5 more
europepmc +1 more source
Clinical Application of Pharmacogenomics in Stroke Management: Current Evidence and Future Directions. [PDF]
Lee KJ +18 more
europepmc +1 more source
Protein Levels of 16 Cytochrome P450s and 2 Carboxyl Esterases Using Absolute Quantitative Proteomics: CYP2C9 and CYP3A4 Are the Most Abundant Isoforms in Human Liver and Intestine, Respectively. [PDF]
Grangeon A +5 more
europepmc +1 more source
Investigating the effects of air pollution on papillary thyroid cancer based on network toxicology and molecular docking. [PDF]
Chen Z +5 more
europepmc +1 more source
Prevalence of risk phenotypes associated with <i>CYP2C9*2, *3,</i> and <i>VKORC1 c.-1639G>A</i> genetic polymorphisms in world populations: implications in clinical practice. [PDF]
Biswas M +6 more
europepmc +1 more source
Clinical Pharmacogenomic Variants Among the Saudi Population and Their Impact on Drug Response: A Review of Saudi-Based Evidence. [PDF]
Alqurain A +14 more
europepmc +1 more source
The Activation of Cytochrome P450 2C9 Is Facilitated by the Coenzyme Forms of Vitamin B2. [PDF]
Koroleva PI +5 more
europepmc +1 more source
Self-Reported Pharmacogenetic Medication Use in the Our Future Health Cohort. [PDF]
Dixon P +4 more
europepmc +1 more source
Medical Marijuana and Treatment Personalization: The Role of Genetics and Epigenetics in Response to THC and CBD. [PDF]
Kalak M +3 more
europepmc +1 more source
Identification and validation of icaritin-associated prognostic genes in hepatocellular carcinoma through network pharmacology, bioinformatics analysis, and cellular experiments. [PDF]
Shi Y +7 more
europepmc +1 more source

